The global neurostimulation devices market is experiencing substantial growth, driven by advancements in technology and an increasing prevalence of neurological disorders. The market size is projected to expand from USD 11.1 billion in 2022 to USD 36.5 billion by 2032, growing at a compound annual growth rate (CAGR).
FDA has issued a Class I recall of 155,028 Abbott Medical implantable neurostimulation systems due to an inability to exit MRI mode, potentially leading to seri
Newark, New Castle, USA, July 04, 2023 (GLOBE NEWSWIRE) According to the recent analysis conducted by Growth Plus Reports, the global peripheral nerve.
Spinal Cord Stimulators for Chronic Back Pain Okayed by FDA everydayhealth.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from everydayhealth.com Daily Mail and Mail on Sunday newspapers.